ORCHIDPHAR

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that :- 1) Dr. I Seetharam Naidu, Director has acquired 9,000 shares of Orchid Chemicals & Pharmaceuticals Ltd.on May 19, 2006 and May 22, 2006. The mode of acquisition is Market Purchase and the shareholding of Dr. I Seetharam Naidu after the said acquisition is 3,84,280 shares aggregating to 0.58% of the share capital of Orchid Chemicals & Pharmaceuticals Ltd.. 2) Mr. Raj Rajkumar, Director has acquired 10,000 shares on May 19, 2006 of Orchid Chemicals & Pharmaceuticals Ltd.. The mode of acquisition is Market Purchase and the s

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that Dr. I Seetharam Naidu, Director has sold 10,000 shares on March 10, 2006. The shareholding of I Seetharam Naidu after the said sale is 3,77,280 shares aggregating to 0.61% of the share capital of Orchid Chemicals & Pharmaceuticals Ltd.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that I Seetharam Naidu, Director has sold 8,000 shares on February 23, 2006 and February 24, 2006. The shareholding of I Seetharam Naidu after the said sale is 3,87,280 shares aggregating to 0.63% of the share capital of Orchid Chemicals & Pharmaceuticals Ltd.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that I Seetharam Naidu has sold 12,000 shares on February 15, 2006. The shareholding of I Seetharam Naidu after the said sale is 3,96,280 shares aggregating to 0.64% of the share capital of Orchid Chemicals & Pharmaceuticals Ltd.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that I Seetharam Naidu has sold 2000 shares on February 03, 2006. The shareholding of I Seetharam Naidu after the said sale is 4,08,280 shares aggregating to 0.66% of the share capital of Orchid Chemicals & Pharmaceuticals Ltd.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that Right On Time Limited ("Seller") has sold 37,93,935 shares aggregating to 6.16% of the total paid up capital of Orchid Chemicals & Pharmaceuticals Ltd during the period January 12, 2006 to January 19, 2006. The mode of sale is Open Market Sale and the shareholding of Right On Time Limited after the said sale is 10,00,000 shares aggregating to 1.62% of the total paid up capital of Orchid Chemicals & Pharmaceuticals Ltd.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that Raj Rajkumar has acquired shares of Orchid Chemicals & Pharmaceuticals Ltd as follows: (1) On November 16, 2005 - 20,000 shares; (2) On November 22, 2005 - 16,000 shares and (3) On November 23, 2005 - 4,000 shares. The mode of acquisition is Market purchase and the shareholding of Raj Rajkumar after the said acquisition is 40,000 shares of Orchid Chemicals & Pharmaceuticals Ltd.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the promoter Shri K Raghavendra Rao has purchased 60,000 equity shares of Rs. 10/- each of the Company from the secondary market. Consequent to this purchase, Shri K Raghavendra Rao holds 66,15,173 equity shares of the Company constituting 10.86% of the total capital of the Company.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the promoter Shri K Raghavendra Rao has purchased 2,75,000 equity shares of Rs. 10/- each of the Company from the secondary market. Consequent to this purchase, Shri K Raghavendra Rao holds 65,55,173 equity shares of the Company constituting 10.77% of the total capital of the Company.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that HSBC Global Investment Fund along with PAC: HSBC Investments (Hong Kong) Limited has acquired 4,600,000 GDRs aggregating to 7.57% of the total share capital of the Orchid Chemicals & Pharmaceuticals Ltd on October 28, 2005. The mode of acquisition is through GDRs Offering and the shareholding of HSBC Global Investments Fund along with PAC: HSBC Investments (Hong Kong) Limited after the said acquisition is 4,600,000 GDRs of Orchid Chemicals & Pharmaceuticals Ltd.

HSBC Investments (Hongkong) Limited has informed the Exchange that HSBC Global Investment Funds - A/C HSBC Global Investment Funds (Mauritius) Limited alongwith HSBC Investments (Hongkong) Limited (PAC) has acquired 46,00,000 shares of Orchid Chemicals & Pharmaceuticals Limited on October 28, 2005. The mode of acquisition is through GDRs Offering and the shareholding of HSBC Global Investment Funds - A/ C HSBC Global Investment Funds (Mauritius) Limited alongwith HSBC Investments (Hongkong) Limited (PAC) after the said acquisition is 46,00,000 shares aggregating to 7.57% of the total paid up c

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that consequent to the sale of 4,000 shares,Dr.M R Girinath,Director holds 1,92,956 shares of Orchid Chemicals & Pharmaceuticals Ltd. as on December 07,2004

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that International Finance Corporation (IFC) have sold 839850 shares in the secondary market on various dates. Consequently, IFC holds 2188377 shares of Orchid Chemicals & Pharmaceuticals Ltd as of November 24, 2004.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that consequent to the sale of 5,000 shares, Dr. M R Girinath, Director holds 1,97,956 shares of the Company as on September 27, 2004. Further, Mr. Deepak Vaidya, Director's shareholding as on September 30, 2004 has become nil, pursuant to the sale of 3,500 shares held by him.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that consequent to the sale of 5,000 shares, Dr. M R Girinath, Director holds 2,02,956 shares of the company as on September 23, 2004.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that International Finance Corporation (IFC) have sold 6,51,100 shares in the secondary market on various dates. Consequently, IFC holds 30,28,227 shares of Orchid Chemicals & Pharmaceuticals Ltd as of August 30, 2004.